Seattle Genetics, Millennium Get EU Recommendation for Lymphoma Drug – Xconomy

WA-based biotech company (NASDAQ: SGEN) said today that its partner, Cambridge, MA-based Millenium: The Takeda Oncology Company, got a positive recommendation for brentuximab vedotin (Adcetris) from the Committee for Medicinal Products for …